From Texas to Hong Kong–Newton scales up!
Newton™ (Formerly Neurolens®; Coppell, TX, USA) has recently announced a major step in its global growth by partnering with Hong Kong Optical Lens Co. Ltd. (HKO) to distribute its full portfolio of diagnostic and lens technologies across Hong Kong and mainland China–including the Neurolens Therapeutic System and Sequel™ Everyday Lens.
This collaboration aims to bring Newton’s diagnostic and therapeutic technologies in the two markets where there is a higher usage of digital services and an increasing case of digital eye strain.
In a press statement, Davis Corley, Newton CEO said, “This partnership marks a pivotal moment in Newton’s global expansion. Hong Kong Optical Lens’ market expertise positions us to bring relief to millions experiencing headaches, neck pain, motion sickness, and digital eye strain. This is just the beginning of Newton’s international growth.”
Furthermore, Eddie So, Managing Director of Hong Kong Optical Lens, added, “Our legacy is rooted in a partner-first philosophy, working closely with global brands, to transform market insights into reality. We are excited to partner with Newton to bring the cutting-edge Neurolens and Sequel technologies to Hong Kong and China.”
Newton and HKO expansion for eye care
Newton’s expansion in Hong Kong is also supported by HKO’s strategic partner–CMER Eye Centers–where the Neurolens N3 measurement device is already integrated in their centers’ practice.The companies considered this step a new start for a widespread use of objective measurement of eye misalignment.
In support of advancing eye care education, HKO and Newton have already donated Neurolens N3 devices to The Hong Kong Polytechnic University School of Optometry, one of the most prestigious optometry programs in Asia, to train the next generation of eye care professionals on how to use such innovative technologies.
READ MORE: Eye-Opening Contact Tidbits: 10 fun facts about lenses to amaze and surprise your patients
Understanding Newton’s technologies
The Neurolens N3 device enables objective assessment in eye misalignment of different viewing distances.This device uses a therapeutic lens with Contoured Prism™ technology which lessens visual misalignment among patients; misalignments that, if not properly addressed, can lead to headaches, neck pain, motion sickness and eye strain.
On the other hand, the Sequel™ Everyday Lens is designed for daily wear to prevent and lessen digital eye strain. The lens’ Convergence Boost™ technology aims to provide comfortable vision to individuals using digital devices for an extended amount of time.
READ MORE: Seeing Through the Hype?
The takeaway
Overall, this partnership signals a shift toward wide access to diagnostic and lens technologies in Hong Kong and China, if not the whole of Asia. As the usage of digital devices increases globally, the number of patients who have digital eye strain also continues to increase.Tools like the Neurolens N3 and Sequel Everyday Lens offer promising help for eye care patients not only in the U.S. but also in Asia.
Editor’s Note: This content is intended exclusively for healthcare professionals. It is not intended for the general public. Products or therapies discussed may not be registered or approved in all jurisdictions, including Singapore.